WHO Drug Information Vol. 24, No. 4, 2010

WHO Drug Information, Vol. 24, No. 4, 2010 Proposed INN: List 104C 29 H 38 FN 3 O 5 751475-53-3H 3 COFNHH 3 CCH 3NCH 3H 3 COONOCH 3Oavagacestatumavagacestatavagacestatavagacestat(2R)-2-(4-chloro-N-{[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phenyl]methyl}benzenesulfonamido)-5,5,5-trifluoropentanamidegamma secretase inhibitor(2R)-2-(4-chloro-N-{[2-fluoro-4-(1,2,4-oxadiazol-3-yl)phényl]méthyl}benzenesulfonamido)-5,5,5-trifluoropentanamideinhibiteur de la secrétase gamma(2R)-2-(4-cloro-N-{[2-fluoro-4-(1,2,4-oxadiazol-3-yl)fenil]metil}bencenosulfonamido)-5,5,5-trifluoropentanamidainhibidor de la secretasa gammaC 20 H 17 ClF 4 N 4 O 4 S 1146699-66-2ONNOO SClNCF 3FOHNH 2bisegliptinumbisegliptinbiségliptinebisegliptinaethyl 4-({2-[(2S,4S)-2-cyano-4-fluoropyrrolidin-1-yl]-2-oxoethyl}amino)bicyclo[2.2.2]octane-1-carboxylateantidiabetic4-({2-[(2S,4S)-2-cyano-4-fluoropyrrolidin-1-yl]-2-oxoéthyl}amino)bicyclo[2.2.2]octane-1-carboxylate d'éthyleantidiabétique4-({2-[(2S,4S)-2-ciano-4-fluoropirrolidin-1-il]-2-oxoetil}amino)biciclo[2.2.2]octano-1-carboxilato de etilohipoglucemianteC 18 H 26 FN 3 O 3 862501-61-9H 3 COOHNOH CNNFH359